Bombesin, but not amylin, blocks the orexigenic effect of peripheral ghrelin

American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
Peter KobeltHubert Mönnikes

Abstract

The interaction between ghrelin and bombesin or amylin administered intraperitoneally on food intake and brain neuronal activity was assessed by Fos-like immunoreactivity (FLI) in nonfasted rats. Ghrelin (13 microg/kg ip) increased food intake compared with the vehicle group when measured at 30 min (g/kg: 3.66 +/- 0.80 vs. 1.68 +/- 0.42, P < 0.0087). Bombesin (8 microg/kg) injected intraperitoneally with ghrelin (13 microg/kg) blocked the orexigenic effect of ghrelin (1.18 +/- 0.41 g/kg, P < 0.0002). Bombesin alone (4 and 8 microg/kg ip) exerted a dose-related nonsignificant reduction of food intake (g/kg: 1.08 +/- 0.44, P > 0.45 and 0.55 +/- 0.34, P > 0.16, respectively). By contrast, ghrelin-induced stimulation of food intake (g/kg: 3.96 +/- 0.56 g/kg vs. vehicle 0.82 +/- 0.59, P < 0.004) was not altered by amylin (1 and 5 microg/kg ip) (g/kg: 4.37 +/- 1.12, P > 0.69, and 3.01 +/- 0.78, respectively, P > 0.37). Ghrelin increased the number of FLI-positive neurons/section in the arcuate nucleus (ARC) compared with vehicle (median: 42 vs. 19, P < 0.008). Bombesin alone (4 and 8 microg/kg ip) did not induce FLI neurons in the paraventricular nucleus of the hypothalamus (PVN) and coadministered with ghrelin did not alter ghrelin-...Continue Reading

References

Nov 8, 1979·Nature·J GibbsS P Maddison
Jul 1, 1991·Peptides·J E Morley, J F Flood
Jun 1, 1989·The American Journal of Physiology·J C CuberJ A Chayvialle
Mar 1, 1989·The American Journal of Physiology·F W Flynn
Mar 1, 1985·The American Journal of Physiology·I L Taylor, R Garcia
Mar 1, 1982·Physiology & Behavior·P J KulkoskyG P Smith
Jan 1, 1980·Peptides·C F Martin, J Gibbs
Sep 1, 1995·Zeitschrift für Ernährungswissenschaft·T A LutzE Scharrer
Jul 1, 1994·The American Journal of Physiology·J E MorleyM J Walter
Apr 2, 1993·Brain Research·W T ChanceJ E Fischer
May 1, 1994·Gastroenterology·J P GutzwillerC Beglinger
Jan 15, 1993·Brain Research·B BonazY Taché
Jan 1, 1993·Ciba Foundation Symposium·P E SawchenkoW Vale
Apr 1, 1993·Trends in Pharmacological Sciences·T J RinkA Young
Dec 1, 1995·Physiology & Behavior·T A LutzE Scharrer
Dec 1, 1995·Metabolism: Clinical and Experimental·A A YoungK Beaumont
Dec 1, 1996·The American Journal of Physiology·E Yoshida-YonedaY Taché
Jan 1, 1997·Metabolism: Clinical and Experimental·B R GedulinA A Young
Jun 1, 1997·The American Journal of Physiology·G J SchwartzE E Ladenheim
Sep 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·M D BarrachinaY Taché
Aug 29, 1997·Regulatory Peptides·N E RowlandR M Gentry
Aug 1, 1997·Brain Research. Molecular Brain Research·X M GuanA D Howard
Jun 11, 1999·The American Journal of Physiology·D MichaudZ Merali
Sep 21, 2000·The Proceedings of the Nutrition Society·G WilliamsD J Cutler
Nov 1, 2000·Nature·M TschöpM L Heiman

❮ Previous
Next ❯

Citations

Nov 12, 2009·Current Gastroenterology Reports·Andreas Stengel, Yvette Taché
Jan 11, 2008·Current Opinion in Endocrinology, Diabetes, and Obesity·Nieves GonzalezRobert T Jensen
Aug 28, 2010·International Journal of Peptides·Johannes D Veldhuis, Cyril Y Bowers
Dec 25, 2012·Molecular and Cellular Endocrinology·Pierre MiegueuKatherine Cianflone
Dec 1, 2009·Peptides·Andreas StengelYvette Taché
Jul 12, 2016·Brain Research·Kim-Marie EngsterPeter Kobelt
Apr 14, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·T A Lutz
Dec 17, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·M PigeyreUNKNOWN HELENA Study group
Apr 23, 2019·Annals of the New York Academy of Sciences·Raoni C Dos-SantosAndré S Mecawi
Jun 17, 2006·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Thomas A Lutz
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.